Validation of a low-cost, carbon dioxide-based cryoablation system for percutaneous tumor ablation.

Validation of a low-cost, carbon dioxide-based cryoablation system for percutaneous tumor ablation. PLoS One. 2019; 14(7):e0207107.

View in: PubMed